China Influenza Drugs and Vaccines Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Influenza Drugs and Vaccines industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • BioCryst PharmaceuticalsInc

    • Sanofi Pasteur, Inc

    • GlaxoSmithKline

    • Serum Institute Of India Pvt Ltd

    • Emergent Biosolutions

    • CSL Limited

    • Astrazeneca

    • Alvogen

    • Protein Sciences Corporation

    By Type:

    • Trivalent

    • Zanamivir

    • Oseltamivir Phosphate

    • Peramivir

    • Quadrivalent

    By Application:

    • Hospitals

    • Research Laboratories

    • Others

    • Pharmacies

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Influenza Drugs and Vaccines Market Overview 2018-2029

    • 1.1 China Influenza Drugs and Vaccines Industry Development Overview

    • 1.2 China Influenza Drugs and Vaccines Industry Development History

    • 1.3 China Influenza Drugs and Vaccines Industry Market Size (2018-2029)

    • 1.4 China Influenza Drugs and Vaccines Market Analysis by Type from Production Side

      • 1.4.1 China Influenza Drugs and Vaccines Production Volume, Production Value and Growth Rate of Trivalent (2018-2029)

      • 1.4.2 China Influenza Drugs and Vaccines Production Volume, Production Value and Growth Rate of Zanamivir (2018-2029)

      • 1.4.3 China Influenza Drugs and Vaccines Production Volume, Production Value and Growth Rate of Oseltamivir Phosphate (2018-2029)

      • 1.4.4 China Influenza Drugs and Vaccines Production Volume, Production Value and Growth Rate of Peramivir (2018-2029)

      • 1.4.5 China Influenza Drugs and Vaccines Production Volume, Production Value and Growth Rate of Quadrivalent (2018-2029)

    • 1.5 China Influenza Drugs and Vaccines Market Analysis by Application from Consumption End

      • 1.5.1 China Influenza Drugs and Vaccines Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.2 China Influenza Drugs and Vaccines Sales Volume, Sales Value and Growth Rate of Research Laboratories (2018-2029)

      • 1.5.3 China Influenza Drugs and Vaccines Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.4 China Influenza Drugs and Vaccines Sales Volume, Sales Value and Growth Rate of Pharmacies (2018-2029)

    • 1.6 China Influenza Drugs and Vaccines Market Analysis by Region

      • 1.6.1 North China Influenza Drugs and Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Influenza Drugs and Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Influenza Drugs and Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Influenza Drugs and Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Influenza Drugs and Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Influenza Drugs and Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Influenza Drugs and Vaccines Market Size and Growth Rate from 2018-2029

    Chapter 2 China Influenza Drugs and Vaccines Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Influenza Drugs and Vaccines Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Influenza Drugs and Vaccines Market Status and Competition Analysis in 2023

      • 2.2.3 China Influenza Drugs and Vaccines Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Influenza Drugs and Vaccines Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Influenza Drugs and Vaccines Industry Development

    Chapter 3 Influenza Drugs and VaccinesIndustry Chain Analysis

    • 3.1 Influenza Drugs and Vaccines Industry Chain

    • 3.2 Influenza Drugs and Vaccines Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Influenza Drugs and Vaccines Market

    • 3.3 Influenza Drugs and Vaccines Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Influenza Drugs and Vaccines Market

    Chapter 4 China Influenza Drugs and Vaccines Market, by Type

    • 4.1 China Influenza Drugs and Vaccines Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Influenza Drugs and Vaccines Total Production Volume and Growth Rate from Production Side

    • 4.5 China Influenza Drugs and Vaccines Production Volume and Growth Rate, by Type

      • 4.5.1 China Influenza Drugs and Vaccines Production Volume and Growth Rate of Trivalent

      • 4.5.2 China Influenza Drugs and Vaccines Production Volume and Growth Rate of Zanamivir

      • 4.5.3 China Influenza Drugs and Vaccines Production Volume and Growth Rate of Oseltamivir Phosphate

      • 4.5.4 China Influenza Drugs and Vaccines Production Volume and Growth Rate of Peramivir

      • 4.5.5 China Influenza Drugs and Vaccines Production Volume and Growth Rate of Quadrivalent

    Chapter 5 China Influenza Drugs and Vaccines Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Influenza Drugs and Vaccines Total Market Size and Growth Rate from Consumption End

    • 5.5 China Influenza Drugs and Vaccines Market Size and Growth Rate, by Application

      • 5.5.1 China Influenza Drugs and Vaccines Market Size and Growth Rate of Hospitals

      • 5.5.2 China Influenza Drugs and Vaccines Market Size and Growth Rate of Research Laboratories

      • 5.5.3 China Influenza Drugs and Vaccines Market Size and Growth Rate of Others

      • 5.5.4 China Influenza Drugs and Vaccines Market Size and Growth Rate of Pharmacies

    Chapter 6 China Influenza Drugs and Vaccines Market, by Region

    • 6.1 China Influenza Drugs and Vaccines Production Volume and Production Value, by Region

    • 6.2 China Influenza Drugs and Vaccines Sales Volume and Sales Value, by Region

    Chapter 7 North China Influenza Drugs and Vaccines Market Analysis

    • 7.1 North China Influenza Drugs and Vaccines Market, by Type

    • 7.2 North China Influenza Drugs and Vaccines Market, by Application

    Chapter 8 Central China Influenza Drugs and Vaccines Market Analysis

    • 8.1 Central China Influenza Drugs and Vaccines Market, by Type

    • 8.2 Central China Influenza Drugs and Vaccines Market, by Application

    Chapter 9 South China Influenza Drugs and Vaccines Market Analysis

    • 9.1 South China Influenza Drugs and Vaccines Market, by Type

    • 9.2 South China Influenza Drugs and Vaccines Market, by Application

    Chapter 10 East China Influenza Drugs and Vaccines Market Analysis

    • 10.1 East China Influenza Drugs and Vaccines Market, by Type

    • 10.2 East China Influenza Drugs and Vaccines Market, by Application

    Chapter 11 Northeast China Influenza Drugs and Vaccines Market Analysis

    • 11.1 Northeast China Influenza Drugs and Vaccines Market, by Type

    • 11.2 Northeast China Influenza Drugs and Vaccines Market, by Application

    Chapter 12 Southwest China Influenza Drugs and Vaccines Market Analysis

    • 12.1 Southwest China Influenza Drugs and Vaccines Market, by Type

    • 12.2 Southwest China Influenza Drugs and Vaccines Market, by Application

    Chapter 13 Northwest China Influenza Drugs and Vaccines Market Analysis

    • 13.1 Northwest China Influenza Drugs and Vaccines Market, by Type

    • 13.2 Northwest China Influenza Drugs and Vaccines Market, by Application

    Chapter 14 Company Profiles

      • 14.1 BioCryst PharmaceuticalsInc

        • 14.1.1 BioCryst PharmaceuticalsInc Company Profile

        • 14.1.2 BioCryst PharmaceuticalsInc Influenza Drugs and Vaccines Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Sanofi Pasteur, Inc

        • 14.2.1 Sanofi Pasteur, Inc Company Profile

        • 14.2.2 Sanofi Pasteur, Inc Influenza Drugs and Vaccines Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 GlaxoSmithKline

        • 14.3.1 GlaxoSmithKline Company Profile

        • 14.3.2 GlaxoSmithKline Influenza Drugs and Vaccines Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Serum Institute Of India Pvt Ltd

        • 14.4.1 Serum Institute Of India Pvt Ltd Company Profile

        • 14.4.2 Serum Institute Of India Pvt Ltd Influenza Drugs and Vaccines Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Emergent Biosolutions

        • 14.5.1 Emergent Biosolutions Company Profile

        • 14.5.2 Emergent Biosolutions Influenza Drugs and Vaccines Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 CSL Limited

        • 14.6.1 CSL Limited Company Profile

        • 14.6.2 CSL Limited Influenza Drugs and Vaccines Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Astrazeneca

        • 14.7.1 Astrazeneca Company Profile

        • 14.7.2 Astrazeneca Influenza Drugs and Vaccines Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Alvogen

        • 14.8.1 Alvogen Company Profile

        • 14.8.2 Alvogen Influenza Drugs and Vaccines Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Protein Sciences Corporation

        • 14.9.1 Protein Sciences Corporation Company Profile

        • 14.9.2 Protein Sciences Corporation Influenza Drugs and Vaccines Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Influenza Drugs and Vaccines Industry Research Conclusions

    • 15.2 Influenza Drugs and Vaccines Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Influenza Drugs and Vaccines Industry Market Size (2018-2029)

    • Figure China Influenza Drugs and Vaccines Production Volume, Production Value and Growth Rate of Trivalent (2018-2029)

    • Figure China Influenza Drugs and Vaccines Production Volume, Production Value and Growth Rate of Zanamivir (2018-2029)

    • Figure China Influenza Drugs and Vaccines Production Volume, Production Value and Growth Rate of Oseltamivir Phosphate (2018-2029)

    • Figure China Influenza Drugs and Vaccines Production Volume, Production Value and Growth Rate of Peramivir (2018-2029)

    • Figure China Influenza Drugs and Vaccines Production Volume, Production Value and Growth Rate of Quadrivalent (2018-2029)

    • Figure China Influenza Drugs and Vaccines Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Influenza Drugs and Vaccines Sales Volume, Sales Value and Growth Rate of Research Laboratories (2018-2029)

    • Figure China Influenza Drugs and Vaccines Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Influenza Drugs and Vaccines Sales Volume, Sales Value and Growth Rate of Pharmacies (2018-2029)

    • Figure North China Influenza Drugs and Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Central China Influenza Drugs and Vaccines Market Size and Growth Rate from 2018-2029

    • Figure South China Influenza Drugs and Vaccines Market Size and Growth Rate from 2018-2029

    • Figure East China Influenza Drugs and Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Influenza Drugs and Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Influenza Drugs and Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Influenza Drugs and Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Influenza Drugs and Vaccines Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Influenza Drugs and Vaccines Market Share by Type in 2018

    • Figure China Influenza Drugs and Vaccines Market Share by Type in 2023

    • Figure China Influenza Drugs and Vaccines Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Influenza Drugs and Vaccines Production Volume and Growth Rate of Trivalent (2018-2023)

    • Figure China Influenza Drugs and Vaccines Production Volume and Growth Rate of Zanamivir (2018-2023)

    • Figure China Influenza Drugs and Vaccines Production Volume and Growth Rate of Oseltamivir Phosphate (2018-2023)

    • Figure China Influenza Drugs and Vaccines Production Volume and Growth Rate of Peramivir (2018-2023)

    • Figure China Influenza Drugs and Vaccines Production Volume and Growth Rate of Quadrivalent (2018-2023)

    • Figure China Influenza Drugs and Vaccines Market Share by Application in 2018

    • Figure China Influenza Drugs and Vaccines Market Share by Application in 2023

    • Figure China Influenza Drugs and Vaccines Total Market Size and Growth Rate from Consumption End

    • Figure China Influenza Drugs and Vaccines Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Influenza Drugs and Vaccines Market Size and Growth Rate of Research Laboratories (2018-2023)

    • Figure China Influenza Drugs and Vaccines Market Size and Growth Rate of Others (2018-2023)

    • Figure China Influenza Drugs and Vaccines Market Size and Growth Rate of Pharmacies (2018-2023)

    • Table China Influenza Drugs and Vaccines Production Volume by Region (2018-2023)

    • Table China Influenza Drugs and Vaccines Production Volume Share by Region (2018-2023)

    • Figure China Influenza Drugs and Vaccines Production Volume Share by Region (2018-2023)

    • Table China Influenza Drugs and Vaccines Production Value by Region (2018-2023)

    • Table China Influenza Drugs and Vaccines Production Value Share by Region (2018-2023)

    • Figure China Influenza Drugs and Vaccines Production Value Share by Region (2018-2023)

    • Table China Influenza Drugs and Vaccines Sales Volume by Region (2018-2023)

    • Table China Influenza Drugs and Vaccines Sales Volume Share by Region (2018-2023)

    • Figure China Influenza Drugs and Vaccines Sales Volume Share by Region (2018-2023)

    • Table China Influenza Drugs and Vaccines Sales Value by Region (2018-2023)

    • Table China Influenza Drugs and Vaccines Sales Value Share by Region (2018-2023)

    • Figure China Influenza Drugs and Vaccines Sales Value Share by Region (2018-2023)

    • Table North China Influenza Drugs and Vaccines Production Volume by Type (2018-2023)

    • Table North China Influenza Drugs and Vaccines Production Volume Share by Type (2018-2023)

    • Figure North China Influenza Drugs and Vaccines Production Volume Share by Type (2018-2023)

    • Table North China Influenza Drugs and Vaccines Sales Volume by Application (2018-2023)

    • Table North China Influenza Drugs and Vaccines Sales Volume Share by Application (2018-2023)

    • Figure North China Influenza Drugs and Vaccines Sales Volume Share by Application (2018-2023)

    • Table Central China Influenza Drugs and Vaccines Production Volume by Type (2018-2023)

    • Table Central China Influenza Drugs and Vaccines Production Volume Share by Type (2018-2023)

    • Figure Central China Influenza Drugs and Vaccines Production Volume Share by Type (2018-2023)

    • Table Central China Influenza Drugs and Vaccines Sales Volume by Application (2018-2023)

    • Table Central China Influenza Drugs and Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Central China Influenza Drugs and Vaccines Sales Volume Share by Application (2018-2023)

    • Table South China Influenza Drugs and Vaccines Production Volume by Type (2018-2023)

    • Table South China Influenza Drugs and Vaccines Production Volume Share by Type (2018-2023)

    • Figure South China Influenza Drugs and Vaccines Production Volume Share by Type (2018-2023)

    • Table South China Influenza Drugs and Vaccines Sales Volume by Application (2018-2023)

    • Table South China Influenza Drugs and Vaccines Sales Volume Share by Application (2018-2023)

    • Figure South China Influenza Drugs and Vaccines Sales Volume Share by Application (2018-2023)

    • Table East China Influenza Drugs and Vaccines Production Volume by Type (2018-2023)

    • Table East China Influenza Drugs and Vaccines Production Volume Share by Type (2018-2023)

    • Figure East China Influenza Drugs and Vaccines Production Volume Share by Type (2018-2023)

    • Table East China Influenza Drugs and Vaccines Sales Volume by Application (2018-2023)

    • Table East China Influenza Drugs and Vaccines Sales Volume Share by Application (2018-2023)

    • Figure East China Influenza Drugs and Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northeast China Influenza Drugs and Vaccines Production Volume by Type (2018-2023)

    • Table Northeast China Influenza Drugs and Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northeast China Influenza Drugs and Vaccines Production Volume Share by Type (2018-2023)

    • Table Northeast China Influenza Drugs and Vaccines Sales Volume by Application (2018-2023)

    • Table Northeast China Influenza Drugs and Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Influenza Drugs and Vaccines Sales Volume Share by Application (2018-2023)

    • Table Southwest China Influenza Drugs and Vaccines Production Volume by Type (2018-2023)

    • Table Southwest China Influenza Drugs and Vaccines Production Volume Share by Type (2018-2023)

    • Figure Southwest China Influenza Drugs and Vaccines Production Volume Share by Type (2018-2023)

    • Table Southwest China Influenza Drugs and Vaccines Sales Volume by Application (2018-2023)

    • Table Southwest China Influenza Drugs and Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Influenza Drugs and Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northwest China Influenza Drugs and Vaccines Production Volume by Type (2018-2023)

    • Table Northwest China Influenza Drugs and Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northwest China Influenza Drugs and Vaccines Production Volume Share by Type (2018-2023)

    • Table Northwest China Influenza Drugs and Vaccines Sales Volume by Application (2018-2023)

    • Table Northwest China Influenza Drugs and Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Influenza Drugs and Vaccines Sales Volume Share by Application (2018-2023)

    • Table BioCryst PharmaceuticalsInc Company Profile

    • Table BioCryst PharmaceuticalsInc Influenza Drugs and Vaccines Revenue, Price and Gross (2018-2023)

    • Table Sanofi Pasteur, Inc Company Profile

    • Table Sanofi Pasteur, Inc Influenza Drugs and Vaccines Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Influenza Drugs and Vaccines Revenue, Price and Gross (2018-2023)

    • Table Serum Institute Of India Pvt Ltd Company Profile

    • Table Serum Institute Of India Pvt Ltd Influenza Drugs and Vaccines Revenue, Price and Gross (2018-2023)

    • Table Emergent Biosolutions Company Profile

    • Table Emergent Biosolutions Influenza Drugs and Vaccines Revenue, Price and Gross (2018-2023)

    • Table CSL Limited Company Profile

    • Table CSL Limited Influenza Drugs and Vaccines Revenue, Price and Gross (2018-2023)

    • Table Astrazeneca Company Profile

    • Table Astrazeneca Influenza Drugs and Vaccines Revenue, Price and Gross (2018-2023)

    • Table Alvogen Company Profile

    • Table Alvogen Influenza Drugs and Vaccines Revenue, Price and Gross (2018-2023)

    • Table Protein Sciences Corporation Company Profile

    • Table Protein Sciences Corporation Influenza Drugs and Vaccines Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.